APAC CIO Outlook
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • Atlassian

    CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Content Management System

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    ERP

    Field Service

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Product Management

    RegTech

    Revenue Management

    Sales Tech

Menu
    • Augmented Reality
    • Agile
    • Cognitive
    • Cyber Security
    • Digital Transformation
    • Atlassian
    • E-Commerce
    • Managed Services
    • RegTech
    • CISCO
    • Blockchain
    • IoT
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Healthcare
    Editor's Pick (1 - 4 of 8)
    left
    Technology’s Role in The Care and Quality of Life for The Aged

    Jose A Perez, Chief Information Officer, Hammondcare

    Digital Transformation - The Right Way

    Amit Goel, CIO, Metropolis Healthcare

    The (E-) Doctor Is In: What Trends to Spot in Healthcare Technology Today

    Dickon Smart-Gill, CIO, Bumrungrad International Hospital

    Analytics and AI in Healthcare

    Steven Parrish, CIO, Taranaki District Health Board

    Document Management in the Cloud

    Alex Choy, EVP R&D CIO, Change Healthcare

    China Embracing Connected Health

    Geoff Feakes, Group CIO, Tunstall Healthcare

    How Healthy is Your IT?

    John Sutherland-CIO-Ramsay Health Care

    Enterprise Architecture - An Extremely Valuable Discipline for Great Businesses

    Ken Spangler, SVP & CIO FedEx Ground and FedEx Freight, FedEx Services IT

    right

    Gero Secures $2.2 Million to Develop its AI Platform Further

    By Apac CIO Outlook | Tuesday, August 11, 2020
    Tweet

    The platform is also being utilized to develop drugs in other areas, such as finding potential therapies for COVID-19, including those that could reduce mortality from complications related to aging

    FREMONT, CA: Gero, a Singapore-based company that develops new drugs for aging and other complicated disorders using its proprietary developed artificial intelligence (AI) platform, secured $2.2m in Series A funding. The latest funding brings the total capital raised to over $7.5m.

    Bulba Ventures led the round with participation from previous investors and serial entrepreneurs in the fields of pharmaceuticals, IT, and AI. The co-founder of Bulba Ventures Yury Melnichek joined Gero’s Board of Directors.

    Led by founder Peter Fedichev, the startup will use the new funds to further develop its AI platform for analyzing clinical and genetic data to identify treatments for chronic aging-related diseases, mental disorders, and other diseases.

    The company’s experts use massive datasets of medical and genetic information from a large number of people acquired via biobanks and create a proprietary database of blood samples collected throughout the last 15 years of the patients’ lives. By utilizing this data, the platform determines the protein circulating in people’s blood, and upon removing or blocking should lead to rejuvenation. Subsequent experiments at the National University of Singapore involved aged animals, which showed mortality delay (life-extension) and functional improvements after a single experimental treatment. In the future, this new drug could enable patients to recover after a stroke and could enable cancer patients in their fight against accelerated aging resulting from chemotherapy.

    The platform is currently also being utilized to develop drugs in other areas, such as finding potential therapies for COVID-19, including those that could reduce mortality from complications related to aging. It has already attracted a great deal of attention from large pharmaceutical companies and leading global media organizations.

    Check Out: Top Big Data Companies in APAC

    tag

    Big Data

    Pharmaceutical

    Weekly Brief

    loading
    ON THE DECK

    Retail 2021

    Top Vendors

    Compliance 2021

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    The Advantages of Blockchain in lot

    The Advantages of Blockchain in lot

    Three Benefits of Deploying Cloud Telephony System

    Three Benefits of Deploying Cloud Telephony System

    Technology Trends that Bring Revolutionary Changes in the Way Education Imparted Before

    Technology Trends that Bring Revolutionary Changes in the Way Education Imparted Before

    What Is the Role of AI in Managed Services?

    What Is the Role of AI in Managed Services?

    Four Mistakes to Avoid when Implementing Digital Transformation

    Four Mistakes to Avoid when Implementing Digital Transformation

    How Edge Computing will Address IoT Challenges?

    How Edge Computing will Address IoT Challenges?

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/gero-secures-22-million-to-develop-its-ai-platform-further-nwid-7664.html